LH - NYSE

Labcorp Holdings Inc.

LH·NYSE

$258.92

+0.47%

HealthcareMedical - Diagnostics & Research

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$21.23B

EPS10.5400

P/E Ratio23.81

Earnings Date07/23/2026

13.95B

Revenue

3Y+18.0%

5Y-

10Y+45.0%

876.50M

Net Income

17%

3Y-31.0%

5Y-44.0%

10Y+20.0%

1.64B

Operating Cash Flow

3Y-16.0%

5Y-23.0%

10Y+40.0%

Labcorp Holdings Inc. Profit Bridge

LH · NYSE

Revenue & Cost of Sales

Revenue13.95B

Cost of Goods Sold (10.22B)

Gross Profit3.73B

Operating Expenses

Operating Expenses (2.22B)

Operating Income1.52B

Other Income & Taxes

Interest Expense (224.10M)

Other Income/Expense-408.70M

Pretax Income1.11B

Income Tax (229.80M)

Net Income876.50M

Net Income

876.50M

Profitability Analysis

Gross Margin

26.8%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

10.9%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

6.3%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

20.7%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

Room for improvement: Moderate profitability with opportunities to enhance margins through better cost management or pricing strategy.

Labcorp Holdings Inc. Income Statement

LH • NYSE

Labcorp Holdings Inc. Income Statement	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
REVENUE
Revenue	14B	13B	12.2B	11.9B	13.1B	14B	11.6B	11.3B	10.4B	9.6B	8.7B	6B	5.8B	5.7B	5.5B	5B	4.7B	4.5B	4.1B	3.6B
GROSS PROFIT
Cost of Revenue	(10.2B)	(9.4B)	(8.8B)	(8.2B)	(8.1B)	(9B)	(8.3B)	(8.2B)	(7B)	(6.5B)	(5.8B)	(3.8B)	(3.6B)	(3.4B)	(3.3B)	(2.9B)	(2.7B)	(2.6B)	(2.4B)	(2.1B)
Gross Profit	3.7B	3.6B	3.4B	3.7B	5B	5B	3.3B	3.2B	3.5B	3.2B	2.9B	2.2B	2.2B	2.2B	2.3B	2.1B	2B	1.9B	1.7B	1.5B
OPERATING INCOME
Operating Expenses	(2.2B)	(2.5B)	(2.6B)	(2.3B)	(1.9B)	(2.5B)	(1.9B)	(1.8B)	(2B)	(1.8B)	(1.8B)	(1.3B)	(1.2B)	(1.2B)	(1.2B)	(1.1B)	(1B)	(1B)	(863.6M)	(831.3M)
Selling, General & Administrative	(2.2B)	(2.2B)	(2B)	(2B)	(1.7B)	(1.7B)	(1.6B)	(1.6B)	(1.8B)	(1.6B)	(1.6B)	(1.2B)	(1.1B)	(1.1B)	(1.2B)	(1B)	(958.9M)	(935.1M)	(808.7M)	(779.1M)
Research & Development	(0.0)	(0.0)	(2M)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)
Operating Income	1.5B	1.1B	725.6M	1.4B	3B	2.4B	1.3B	1.3B	1.4B	1.3B	1B	910.4M	990.9M	1B	948.4M	978.8M	935.9M	842.9M	777M	697.1M
PRE-TAX INCOME
Interest Expense	(224.1M)	(208.3M)	(199.6M)	(179.8M)	(211.8M)	(207.4M)	(240.7M)	(244.2M)	(235.1M)	(219.1M)	(274.9M)	(109.5M)	(96.5M)	(94.5M)	(87.5M)	(70M)	(62.9M)	(72M)	(0.0)	(0.0)
Net Interest Income	-208.9M	-208.3M	-199.6M	-179.8M	-211.8M	-207.4M	-240.7M	-244.2M	-235.1M	-219.1M	-274.9M	-109.5M	-96.5M	-94.5M	-87.5M	-70M	-61.3M	-69.5M	0.0	0.0
Other Expenses	(0.0)	(307.7M)	(615.9M)	(275.8M)	(253.5M)	(778.1M)	(243.2M)	(167.7M)	-7.6M	(2.6M)	-7.8M	(10.4M)	(2.1M)	-7.2M	(85.8M)	(72.7M)	(62.6M)	(57.9M)	(54.9M)	(52.2M)
Total Other Income Expenses Net	-408.7M	-127.2M	-156.7M	-199.1M	-161M	-226.3M	-225.3M	-57.4M	-227.7M	-206.9M	-270.8M	-83.7M	-75.3M	-79.3M	-82.3M	-63.2M	-51.3M	-57.2M	25.3M	23.8M
Income Before Tax	1.1B	959.5M	568.9M	1.2B	2.9B	2.2B	1.1B	1.3B	1.1B	1.1B	732.1M	826.7M	915.6M	944.2M	866.1M	915.6M	884.6M	772.4M	802.3M	720.9M
NET INCOME
Income Tax Expense	(229.8M)	(212.4M)	(188.5M)	(233.9M)	(690M)	(662.1M)	(280M)	(384.4M)	-139.1M	(372.3M)	(294.1M)	(314.1M)	(340.2M)	(359.4M)	(333M)	(344M)	(329M)	(307.9M)	(325.5M)	(289.3M)
Net Income	876.5M	746M	418M	1.3B	2.4B	1.6B	823.8M	883.7M	1.3B	732.1M	436.9M	511.2M	573.8M	583.1M	519.7M	558.2M	543.3M	464.5M	476.8M	431.6M

SEC Filings

LH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 27, 2026	May 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 26, 2026	May 21, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 04, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 10, 2026	April 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 09, 2026	April 08, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 31, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 20, 2026	March 20, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 24, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 17, 2026	February 17, 2026	2026	View Filing

Showing 1 to 10 of 1290 filings

Related Guides

Blog Categories

Continue your LH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.